Inventor · disambiguated record
Kirk Robarge
Also filed as: ROBARGE KIRK · ROBARGE KIRK D
19 granted patents·6 pending applications·190 citations·filing 1993–2017
94Inventor score
Files withGENENTECH INC15ARRAY BIOPHARMA INC5PEI ZHONGHUA2GOLDSMITH RICHARD A1GOODACRE SIMON CHARLES1
Top patents by PatentIndex Score
25 records- 0193US8697715B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Apr 15, 2014·21 cites·25 claims
- 0289US6472393B1Serine protease inhibitorsGENENTECH INC·Filed 2000·Granted Oct 29, 2002·37 cites·19 claims
- 0389US5565449ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1995·Granted Oct 15, 1996·42 cites·7 claims
- 0488US8486950B2Janus kinase inhibitor compounds and methodsGOODACRE SIMON CHARLES·Filed 2010·Granted Jul 16, 2013·25 cites·19 claims
- 0585US9259470B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Feb 16, 2016·6 cites·45 claims
- 0683US9708290B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jul 18, 2017·3 cites·12 claims
- 0780US9388171B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jul 12, 2016·6 cites·2 claims
- 0877US8288381B2N-9 substituted purine compounds, compositions and methods of usePEI ZHONGHUA·Filed 2010·Granted Oct 16, 2012·3 cites·26 claims
- 0976US8101610B2Bisamide inhibitors of hedgehog signalingGOLDSMITH RICHARD A·Filed 2006·Granted Jan 24, 2012·5 cites·20 claims
- 1069US5674863ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1995·Granted Oct 7, 1997·11 cites·7 claims
- 1169US5663166ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1995·Granted Sep 2, 1997·11 cites·7 claims
- 1266US5674865ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIaGENENTECH INC·Filed 1995·Granted Oct 7, 1997·9 cites·7 claims
- 1358US10519126B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 31, 2019·0 cites·4 claims
- 1458US2007037813A1Serine Protease InhibitorsGENENTECH INC·Filed 2006·Application pending·0 cites
- 1554US2005186198A1Serine protease inhibitorsGENENTECH INC·Filed 2005·Application pending·0 cites
- 1652US6919369B2Serine protease inhibitorsGENENTECH INC·Filed 2002·Granted Jul 19, 2005·0 cites·17 claims
- 1749US5716951ATricyclic inhibitors of the vitronectin receptorGENENTECH INC·Filed 1995·Granted Feb 10, 1998·3 cites·7 claims
- 1849US5705890ATricyclic inhibitors of the GPIIb IIIa receptorGENENTECH INC·Filed 1994·Granted Jan 6, 1998·6 cites·13 claims
- 1946US7109326B2Halo-alkoxycarbonyl prodrugsGENENTECH INC·Filed 2004·Granted Sep 19, 2006·0 cites·5 claims
- 2045US2014206702A1Imidazopyridine compounds, compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2138US5493020ATricyclic inhibitors of the GPIIb IIIa receptorGENENTECH INC·Filed 1993·Granted Feb 20, 1996·2 cites·5 claims
- 2238US2013096104A1Imidazopyridine compounds, compositions and methods of useLAI YINGJIE·Filed 2011·Application pending·0 cites
- 2335US2017001990A1Piperidine-dione derivativesGENENTECH INC·Filed 2016·Application pending·0 cites
- 2434US8828990B2N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of usePEI ZHONGHUA·Filed 2010·Granted Sep 9, 2014·0 cites·11 claims
- 2530US2001020019A1Novel halo-alkoxycarbonyl prodrugsGENENTECH INC·Filed 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →